RG
ABMD

Redmile Group’s Abiomed Inc ABMD Stock Holding History

Redmile Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-326,189
Closed -$7.03M – 62
2013
Q2 		$7.03M Buy
+326,189
New +$6.56M 1.24% 32

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Redmile Group's ABMD Position: Q3 2013 in Review

Redmile Group sold out of Abiomed Inc (ABMD) in Q3 2013, closing a stake of 326,189 shares — an estimated $7.03M sold.

Redmile Group first reported a position in ABMD in Q2 2013 and held it in 1 quarter. The position peaked at $7.03M in Q2 2013. 122 funds tracked by Wall St. Rank hold ABMD as of Q3 2013.

  • Redmile Group reported no remaining Abiomed Inc position as of Q3 2013 after selling out during the quarter.
  • Redmile Group sold 326,189 Abiomed Inc shares in Q3 2013, an estimated $7.03M.
  • Redmile Group first reported a position in Abiomed Inc in Q2 2013 and held it in 1 quarter.
  • Redmile Group's Abiomed Inc position peaked at $7.03M in Q2 2013.
  • 122 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2013.

Based on Redmile Group's 13F filing for Q3 2013, filed 14 Nov 2013.